FDA Inspection
Long Island Jewish Medical CenterLong Island Jewish Medical Center – FDA Inspection, May 1, 2026
Record Details
This FDA Inspection record concerns Long Island Jewish Medical Center, with an inspection on May 1, 2026, issued by the New York District Office.
- Inspection Date
- May 1, 2026
View Company Profile
ID · d5f3bab9-628a-41d7-8637-5ab23b796ec8
Inspection Facts
- Inspection number
- 1314888
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Long Island Jewish Medical Center
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 10, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 30, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 24, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 16, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Long Island Jewish Medical Center
- FDA Inspection 1233005 - 2024-03-15
- FDA Inspection 1164119 - 2022-03-10
- FDA Inspection 1053717 - 2018-05-30
- FDA Inspection 952433 - 2015-11-24
- FDA Inspection 862451 - 2014-01-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.